|
Yes, n (%) |
No, n (%) |
Don’t know, n (%) |
Knowledge regarding epidemiology of cervical cancer |
|
|
|
Is cervical cancer one of the most common cancers among females? |
81 (40.7) |
47 (23.6) |
71 (35.7) |
Are all women at risk of developing cervical cancer? |
59 (29.6) |
77 (38.7) |
63 (31.7) |
Is cervical cancer more common in middle-aged (35-50 years) females? |
76 (38.2) |
48 (24.1) |
75 (37.7) |
Is cervical cancer a communicable disease (transmitted by skin contact, sneezing, coughing)? |
53 (26.6) |
100 (50.3) |
46 (23.1) |
Knowledge regarding HPV |
|
|
|
Is HPV infection rare in Pakistan? |
53 (26.6) |
64 (32.2) |
82 (41.2) |
Can HPV infection affect both males and females? |
97 (48.7) |
35 (17.6) |
67 (33.7) |
Is HPV transmitted by sexual contact? |
108 (54.3) |
16 (8.0) |
75 (37.7) |
Can HPV cause cancers other than cervical cancer? |
72 (36.2) |
16 (8.0) |
111 (55.8) |
Can HPV cause genital warts? |
70 (35.2) |
4 (2.0) |
125 (62.8) |
Knowledge regarding screening of cervical cancer |
|
|
|
Is there any test available for screening of cervical cancer? |
119 (59.8) |
4 (2.0) |
76 (38.2) |
Is Pap smear a screening test for cervical cancer? |
68 (34.2) |
5 (2.5) |
126 (63.3) |
Should screening be initiated at 25 years of age in every female even if asymptomatic? |
68 (34.2) |
37 (18.6) |
94 (47.2) |
Is screening done for sexually active people only? |
68 (34.2) |
49 (24.6) |
82 (41.2) |
Should screening be repeated every three years in every female even if asymptomatic? |
56 (28.1) |
31 (15.6) |
112 (56.3) |
Knowledge regarding prevention of cervical cancer |
|
|
|
Does HPV vaccine prevent cervical cancer? |
80 (40.2) |
13 (6.5) |
106 (53.3) |
Is HPV vaccine given to males and females both? |
79 (39.7) |
29 (14.6) |
91 (45.7) |
Should HPV vaccine be given before 26 years of age? |
51 (25.6) |
29 (14.6) |
119 (59.8) |
Should HPV vaccine be given to sexually active people only? |
61 (30.7) |
45 (22.6) |
93 (46.7) |
Is there any need for screening even after HPV vaccination? |
79 (39.7) |
20 (10.0) |
100 (50.3) |